You just read:

Dragonfly Therapeutics Announces New Multi-Target Collaboration with Merck to Use Dragonfly's Proprietary TriNKET™ Platform to Develop Novel Drug Candidates for Patients with Solid Tumors

News provided by

Dragonfly Therapeutics, Inc.

01 Oct, 2018, 13:58 BST